Explorer les evidences

32 casesOf the 128 participants with genotypes available at timepoint 1, 32 were lost to follow-up before timepoint 2.

KenyaVIH/sidapublié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations

3,01 per_100_person_yearsThe incidence of infant HIV or death was 3.01 per 100 person-years among pregnant women living with HIV in the trial.

KenyaVIH/sidapublié 2021PLoS medicinePubMeddocument de 8 observations

85 %At one-month, PrEP initiation among eligible PrEP-naïve peer clients was 85% as reported by clients.

KenyaVIH/sidapublié 2024Frontiers in public healthPubMeddocument de 7 observations

67,1 %Among HIV-infected children receiving ART in Kenya, 67.1% were virally suppressed in 2018.

KenyaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 10 observations

19,2 %Early loss to follow-up (LTFU) among adolescents and young adults living with HIV (AYALWH) was 19.2% (166 out of 865) in the survey-plus-EMR tool cohort.

KenyaVIH/sidapublié 2023PloS onePubMeddocument de 8 observations

721 g/dDaily breast milk intake of HIV-exposed infants was 721 ± 111 g/d at 6 weeks of age.

KenyaVIH/sidapublié 2023The Journal of nutritionPubMeddocument de 7 observations

8,6 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 8.6% had erythematous candidiasis as the only oral lesion.

Kenyaerythematous candidiasis · VIH/sidapublié 1989Journal of Oral Pathology and MedicineOpenAlexdocument de 8 observations

4 %4% (6/162) of PEP clients reported sexual assault.

KenyaVIH/sidapublié 2025Journal of the International AIDS SocietyPubMeddocument de 19 observations

1,2 %The proportion of infants diagnosed with HIV was 1.2% in the control group.

KenyaVIH/sidapublié 2021Scientific reportsPubMeddocument de 4 observations

963 g/dDaily breast milk intake of HIV-unexposed infants was 963 ± 107 g/d at 6 months of age.

KenyaVIH/sidapublié 2023The Journal of nutritionPubMeddocument de 7 observations

271,78 USDThe estimated unit cost for a HIVDR test was $271.78 per test.

KenyaVIH/sidaobservé 2019publié 2020F1000ResearchPubMeddocument de 3 observations

0,077 pg/μLThe mean plasma aflatoxin B1 concentration was 0.0771 pg/μL among women living with HIV with detectable HIV viral load.

KenyaVIH/sidapublié 2025International journal of STD & AIDSPubMeddocument de 8 observations

48 %Mean predicted risk probability among pregnant and postpartum women with HIV with a new HIV diagnosis was 48% in the moderate-risk quintile.

KenyaVIH/sidapublié 2025AIDS and behaviorPubMeddocument de 13 observations

67 %Of the 94 HIV-attributed cases with documented antemortem diagnoses, 63 (67%) had received antiretroviral therapy.

KenyaVIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations

9 %Of the 658 HIV-1 polymerase sequences analyzed, 58 (9%) were from injecting drug users (IDU).

KenyaVIH/sidaobservé 2005-2019publié 2020Scientific reportsPubMeddocument de 9 observations

15,2 kg/m²Bonferroni correction revealed GC haplotype carriers had low body mass index in antiretroviral treatment-experienced injection substance users (median, 15.2; IQR, 3.2 kg/m²; P=0.002).

KenyaVIH/sidapublié 2020Ethiopian journal of health sciencesPubMeddocument de 7 observations

28,3 %Of the 851 eligible decedents, 241 (28.3%) had evidence of HIV infection.

KenyaVIH/sidaobservé 2019publié 2022BMC public healthPubMeddocument de 6 observations

3,23 prevalence_rate_ratioThe prevalence rate ratio for HIV testing in intervention versus control facilities in the final study quarter was 3.23.

KenyaVIH/sidapublié 2022Implementation science : ISeurope_pmcdocument de 6 observationsDOI 10.1186/s13012-022-01242-3

64,9 %During periods of self-reported HIV risk, time covered by PrEP/PEP was 64.9% in the dynamic choice prevention arm.

KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 18 observations

45,5 %Among maternal caregivers of HIV-positive children, 60 out of 132 (45.5%) reported testing HIV-negative in antenatal care.

KenyaVIH/sidaobservé 2017-2018publié 2020PloS onePubMeddocument de 8 observations

20 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 20 % en 2010.

KenyaVIH/sidaobservé 2010HAL · Unilimdocument de 747 observations

93,8 %The specificity of provider-delivered HIVST at the pharmacy was 93.8% when interpreted by clients.

KenyaVIH/sidaobservé between March and June 2022publié 2023Journal of the International AIDS SocietyPubMeddocument de 9 observations

60 %Leveraging existing community health workers in an integrated HIV/hypertension model reduced the population-level prevalence of uncontrolled hypertension by 60% among people with and without HIV.

Kenyahypertension artérielle · VIH/sidapublié 2025Journal of the International AIDS SocietyPubMeddocument de 11 observations

16 %Of 765 adult patients enrolling in HIV care in East Africa, 16.0% were classified as hyper drinkers.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 7 observations

HIV-positive women with bacterial vaginosis had significantly higher CD4(+)/CD8(+) T-helper cell counts and a lower CD4/CD8 ratio, as well as fewer Tregs as a proportion of total T-helper cells, compared to bacterial vaginosis-negative women.

Kenyavaginose bactérienne · VIH/sidapublié 2012AIDS (London, England)europe_pmcdocument de 3 observationsDOI 10.1097/qad.0b013e32834ed7f0